Roni Scherzer‐Attali

Orally Administrated Cinnamon Extract Reduces β-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer's Disease Animal Models

Anat Frydman‐Marom, Aviad Levin, Dorit Farfara et al. · PLoS ONE · 2011 · 191 citations · Full text

Neurochemical Biomarkers, Corrects Cognitive Impairment, Disease Animal Models +20

Complete Phenotypic Recovery of an Alzheimer's Disease Model by a Quinone-Tryptophan Hybrid Aggregation Inhibitor

Roni Scherzer‐Attali, Riccardo Pellarin, Marino Convertino et al. · PLoS ONE · 2010 · 145 citations · Full text

Amyloid Oligomer Inhibitors, Neurochemical Biomarkers, Chemical Biology +22

Generic inhibition of amyloidogenic proteins by two naphthoquinone–tryptophan hybrid molecules

Roni Scherzer‐Attali, Ronit Shaltiel‐Karyo, Yonatan H. Adalist et al. · Proteins Structure Function and Bioinformatics · 2012 · 52 citations

Quinone-tryptophan Hybrids, Neurochemical Biomarkers, Chemical Biology +17

Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity

Moran Frenkel‐Pinter, Tal Sharon, Roni Scherzer‐Attali et al. · Journal of Alzheimer s Disease · 2016 · 43 citations

Naphthoquinone-tryptophan Hybrid Molecule, Protein Assembly, Cell Death +23

Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model

Roni Scherzer‐Attali, Dorit Farfara, Itzik Cooper et al. · Neurobiology of Disease · 2012 · 38 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Medicine +9